A network pharmacology study to determine the integrated application of dietary plant-derived natural flavonoids and gut microbiota against nonalcoholic fatty liver disease

Author:

Oh Ki-Kwang1,Gupta Haripriya1,Ganesan Raja1,Sharma Satya Priya1,Won Sung-Min1,Jeong Jin-Ju1,Lee Su-Been1,Cha Min-Gi1,Kwon Goo-Hyun1,Jeong Min-Kyo1,Min Byeong-Hyun1,Hyun Ji-Ye1,Eom Jung-A1,Park Hee-Jin1,Yoon Sang-Jun1,Choi Mi-Ran1,Kim Dong Joon1,Suk Ki-Tae1

Affiliation:

1. Institute for Liver and Digestive Diseases, College of Medicine, Hallym University

Abstract

Abstract Background Nonalcoholic fatty liver disease (NAFLD) has been issued in a wide range of complicated progressive interruption such as steatosis, fibrosis, cirrhosis, and even hepatocellular carcinoma. However, a key therapy to unravel the progressive diseases associated with NAFLD has not been established completely among taking many of the potential compounds. In the context of the unfinished project, we comprised metabolites of gut microbiota (endogenous species) and dietary plant-derived natural flavonoids (exogenous species) known as potent antioxidant, antiinflammation, and anticancer, in search for combinatorial effects via network pharmacology analysis. Results We identified the 668 overlapping targets related to metabolites from gut microbiota between SEA and STP; and we selected 14 out of 16 flavonoids because the 2 flavonoids were violated by Lipinski’s rule. The flavonoids’ targets were 112, compared with the 668 overlapping targets to identify the significant targets. Then, we identified the final 47 intersecting targets against NAFLD. On PPI networks, both VEGFA and AKT1 had the highest degree value, which were considered as hub targets against NAFLD. In bubble chart, cAMP signaling pathway was a key mode to be functioned as inhibitive mechanism. On the networks of microbiota (or natural products)-metabolites-targets-key signaling pathway, Enterococcus sp. 45, Escherichia sp.12, Escherichia sp.33, and Bacterium MRG-PMF-1 as key microbiota; flavonoid-rich products as key natural resources; luteolin, and myricetin as key metabolites (or dietary flavonoids); CFTR, PIK3R1, and AKT1 as key targets are potential key components to treat NAFLD, by suppressing cAMP signaling pathway. Conclusion In this study, we suggested that four components (microbiota, metabolites, targets, and a key signaling pathway) and dietary plant-derived natural flavonoids can be exerted combinatorial pharmacological effects against NAFLD.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3